Javascript must be enabled to continue!
Risk Factors for Postoperative Recurrence of Ovarian Endometrioma in Young Women
View through CrossRef
Abstract
Background: Ovarian endometroma seriously affects women's health, and is susceptible to recurrence after surgery. However, only a few studies have been conducted to asses the risk factors for postoperative recurrence of ovarian endometrioma in young women, and no risk factors associated with recurrence have been found. The purpose of this study is to analyse the risk factors for postoperative recurrence of ovarian endometrioma in young women. Materials and Methods: We retrospectively analysed 196 young women who underwent ovarian endometrioma resection in Peking Union Medical College Hospital and Shengjing Hospital from January 2008 to January 2018 and were followed-up for at least 3 years postoperatively. The patients were divided into a recurrence group or a non-recurrence group. Their preoperative histories, laboratory indexes, intraoperative manifestations, and follow-up symptoms were analysed. Results: The cumulative recurrence rate of ovarian endometrioma in young women 3 and 5 years after surgery was 8.0%, and 20.3%, respectively. Univariate analysis showed significant differences in cancer antigen-125 levels (hazard ratio [HR]: 3.207, 95% confidence interval [CI]: 1.126–9.135, P = 0.029), the revised American Fertility Society (rAFS) disease stage (HR: 4.588, 95%CI: 1.422–14.805, P =0.011), postoperative pregnancy (HR: 0.28, 95%CI: 0.109–0.723, P = 0.008), and postoperative dysmenorrhoea (HR: 2.465, 95%CI :1.320–4.604, P = 0.005) between the two groups. Cox multivariate proportional risk analysis showed that rAFS disease stage (HR:3.783, 95%CI: 1.162–12.311, P=0.027) and postoperative dysmenorrhoea (HR: 2.291, 95%CI :1.222–4.296, P = 0.01) were risk factors for postoperative recurrence of ovarian endometrioma, whereas postoperative pregnancy (HR: 0.361, 95%CI: 0.138–0.944, P=0.038) was a protective factor for postoperative recurrence. There was no significant correlation between recurrence of ovarian endometrioma and age at surgery, age at the time of menarche, body mass index, duration of dysmenorrhoea, degree of dysmenorrhoea, genital malformation, surgical approach, maximum diameter of the cyst, and postoperative medication. Conclusion: rAFS disease stage and postoperative dysmenorrhoea are risk factors for the recurrence of ovarian endometrioma during long-term follow-up, whereas postoperative pregnancy is a protective factor.
Springer Science and Business Media LLC
Title: Risk Factors for Postoperative Recurrence of Ovarian Endometrioma in Young Women
Description:
Abstract
Background: Ovarian endometroma seriously affects women's health, and is susceptible to recurrence after surgery.
However, only a few studies have been conducted to asses the risk factors for postoperative recurrence of ovarian endometrioma in young women, and no risk factors associated with recurrence have been found.
The purpose of this study is to analyse the risk factors for postoperative recurrence of ovarian endometrioma in young women.
Materials and Methods: We retrospectively analysed 196 young women who underwent ovarian endometrioma resection in Peking Union Medical College Hospital and Shengjing Hospital from January 2008 to January 2018 and were followed-up for at least 3 years postoperatively.
The patients were divided into a recurrence group or a non-recurrence group.
Their preoperative histories, laboratory indexes, intraoperative manifestations, and follow-up symptoms were analysed.
Results: The cumulative recurrence rate of ovarian endometrioma in young women 3 and 5 years after surgery was 8.
0%, and 20.
3%, respectively.
Univariate analysis showed significant differences in cancer antigen-125 levels (hazard ratio [HR]: 3.
207, 95% confidence interval [CI]: 1.
126–9.
135, P = 0.
029), the revised American Fertility Society (rAFS) disease stage (HR: 4.
588, 95%CI: 1.
422–14.
805, P =0.
011), postoperative pregnancy (HR: 0.
28, 95%CI: 0.
109–0.
723, P = 0.
008), and postoperative dysmenorrhoea (HR: 2.
465, 95%CI :1.
320–4.
604, P = 0.
005) between the two groups.
Cox multivariate proportional risk analysis showed that rAFS disease stage (HR:3.
783, 95%CI: 1.
162–12.
311, P=0.
027) and postoperative dysmenorrhoea (HR: 2.
291, 95%CI :1.
222–4.
296, P = 0.
01) were risk factors for postoperative recurrence of ovarian endometrioma, whereas postoperative pregnancy (HR: 0.
361, 95%CI: 0.
138–0.
944, P=0.
038) was a protective factor for postoperative recurrence.
There was no significant correlation between recurrence of ovarian endometrioma and age at surgery, age at the time of menarche, body mass index, duration of dysmenorrhoea, degree of dysmenorrhoea, genital malformation, surgical approach, maximum diameter of the cyst, and postoperative medication.
Conclusion: rAFS disease stage and postoperative dysmenorrhoea are risk factors for the recurrence of ovarian endometrioma during long-term follow-up, whereas postoperative pregnancy is a protective factor.
Related Results
Risk Factors for Postoperative Recurrence of Ovarian Endometrioma in Young Women
Risk Factors for Postoperative Recurrence of Ovarian Endometrioma in Young Women
Abstract
Purpose
Ovarian endometroma seriously affects women's health, and is susceptible to recurrence after surgery. However, only a few studies have been conducted to a...
What is the impact of endometrioma on IVF/ICSI outcomes in patients with endometriosis: A retrospective study
What is the impact of endometrioma on IVF/ICSI outcomes in patients with endometriosis: A retrospective study
Abstract
Background
Does endometrioma per se, different from endometriosis, have specific impacts on IVF/ICSI outcomes? Dose cystectomy of the endometrioma improve IVF/ICS...
Presence of Endometrioma Decreased Blastocyst Formation Rate but Not Impair Assisted Reproductive Technology (ART) outcome
Presence of Endometrioma Decreased Blastocyst Formation Rate but Not Impair Assisted Reproductive Technology (ART) outcome
Abstract
Purpose: These study aims to assess the impact of endometrioma on patients who undergo ART treatment due to endometriosis.
Methods: Retrospective study was conduct...
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Abstract
Introduction: Pilonidal sinus disease is increasingly recognized in the pediatric population, yet evidence on its clinical characteristics and surgical outcomes in childre...
L26/O-212 The presence of ovarian endometrioma adversely affect the IVF/ ICSI outcomes: a multicenter propensity score–matched study
L26/O-212 The presence of ovarian endometrioma adversely affect the IVF/ ICSI outcomes: a multicenter propensity score–matched study
Abstract
Study question
To evaluate the impact of endometrioma on IVF/ICSI outcomes in patient underwent IVF/ICSI, taking...
Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma
Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma
Background: Endometriosis is a chronic and progressive estrogen-dependent disorder that can result in substantial morbidity, including pelvic pain, multiple operations, and inferti...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
O-133 Effect of non-surgical treatments on the size of endometrioma: A systematic review and Meta-Analysis
O-133 Effect of non-surgical treatments on the size of endometrioma: A systematic review and Meta-Analysis
Abstract
Study question
This review aims to determine the effectiveness of medical preparations in the management of endometriom...

